Search Tag: semaglutide
2024 30 May
Recent research presented at Heart Failure 2024 highlights that semaglutide reduces the necessity for loop diuretics and their dosage while also positively impacting symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF), irrespective of their diuretic regimen. HFpEF occurs when the...Read more
2024 22 May
A recent analysis shows that semaglutide, a prescription drug (brand names Wegovy and Ozempic), may reduce the risk of heart attacks and strokes in individuals, regardless of their weight loss success. Prof John Deanfield from the UCL Institute of Cardiovascular Disease led the study. Researchers analysed data from the Semaglutide and...Read more
2024 17 Apr
Obesity is a global pandemic, with prevalence in the U.S. reaching 42.4% in 2018 and projected to rise to around 50% by 2030. It is linked to chronic medical conditions that increase morbidity and mortality, imposing a substantial burden on annual healthcare spending. Given the high prevalence and adverse impact of obesity on health and healthcare...Read more
2023 25 Aug
In recent breakthrough research presented during a Hot Line session at ESC Congress 2023, semaglutide's effectiveness in improving symptoms and physical function related to heart failure and inducing greater weight loss was reported. Nearly 50% of heart failure patients are affected by heart failure with preserved ejection fraction (HFpEF)....Read more
2023 04 Jul
A recent study conducted by researchers at University College Cork (UCC) and the University of Galway suggests that changing how we discuss obesity is necessary to enhance public understanding of the disease. The researchers propose that the term "obesity" should be renamed to facilitate better comprehension among the public and policymakers, ultimately...Read more
2023 19 Apr
A new study suggests that some anti-obesity medications can be produced and sold at much lower prices than their current high costs, making them more accessible worldwide. The study is published in Obesity. Study authors highlight the need for a public health approach that prioritises improving access to medications instead of allowing...Read more